SCHEMBL4156353

SCHEMBL4156353

CN(C)c1cccnc1-c1ccccn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 9/20 0.48
▸ LMNA P02545 4/20 0.48
▸ HIF1A Q16665 2/20 0.48
▸ CCR1 P32246 2/20 0.48
▸ CCR5 P51681 2/20 0.48
▸ CCR8 P51685 2/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ POLB P06746 1/20 0.48
▸ METAP1 P53582 1/20 0.48
▸ BLM P54132 1/20 0.48
▸ DOHH Q9BU89 1/20 0.48
▸ P4HTM Q9NXG6 1/20 0.48
▸ NPC1 O15118 5/20 0.46
▸ ADORA2A P29274 1/20 0.44
▸ ADORA1 P30542 1/20 0.44
▸ SMN1; SMN2 Q16637 4/20 0.43
▸ MITF O75030 1/20 0.43
▸ RAB9A P51151 4/20 0.42
▸ TP53 P04637 3/20 0.42
▸ HTT P42858 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30636783 1.00 KDM4E (0.48) KDM4ELMNAHIF1ACCR1CCR5
SCHEMBL31627791 0.80 KDM4E (0.43) KDM4ELMNAHIF1ACCR1CCR5
SCHEMBL3791254 0.78 KDM4E (0.50) KDM4ELMNAHIF1ACCR1CCR5
SCHEMBL27658146 0.78 CKS1B (0.46) KDM4ELMNAHIF1ANPC1ADORA2A
SCHEMBL29871060 0.78 KDM4E (0.50) KDM4ELMNAHIF1ACCR1CCR5
SCHEMBL176039 0.74 KDM4E (0.68) KDM4ELMNAHIF1ACCR1CCR5
Dipyridyl SCHEMBL28393736 0.74 KDM4E (0.78) KDM4ELMNAHIF1ACCR1CCR5
SCHEMBL230048 0.74 KDM4E (0.60) KDM4ELMNAHIF1ACCR1CCR5
SCHEMBL29531176 0.74 KDM4E (0.60) KDM4ELMNAHIF1ACCR1CCR5
SCHEMBL8567845 0.73 KDM4E (0.43) KDM4ELMNAHIF1ACCR1CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181941-A1 Pyrrolopyrimidines and Pyrrolopyridines NOVARTIS AG (CH) 2009-07-16 — — US claimed
CN-117616032-A Rare earth complex 东曹株式会社 2024-02-27 — — CN disclosed
CN-107129463-A Dipyridyl derivatives of polyfunctional group substitution and preparation method thereof 福州大学 2017-09-05 — — CN disclosed
CN-105001152-A 11 beta-HSD1 inhibitor of dimethylamino bipyridine tertiary alcohol structure and application thereof FOSHAN SAIWEISI MEDICINE SCIENCE & TECHNOLOGY CO LTD 2015-10-28 — — CN disclosed
CN-105001152-A 11 beta-HSD1 inhibitor of dimethylamino bipyridine tertiary alcohol structure and application thereof FOSHAN SAIWEISI MEDICINE SCIENCE & TECHNOLOGY CO LTD 2015-10-28 — — CN disclosed
CN-1322254-A Small volume in vitro analytical sensor containing diffusible or non-leachable redox mediator THERASENSE INC (US) 2001-11-14 — — CN disclosed
EP-0885183-A1 PROCESS FOR PRODUCING ALDEHYDES BY HYDROFORMYLATION OF OLEFINS BASF AKTIENGESELLSCHAFT (DE) 1998-12-23 — — EP disclosed
WO-1997028113-A1 PROCESS FOR PRODUCING ALDEHYDES BY HYDROFORMYLATION OF OLEFINS BASF AKTIENGESELLSCHAFT (DE) 1997-08-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181941-A1 Pyrrolopyrimidines and Pyrrolopyridines ALK, ACVR1, PTPN4 KDM4E 448/4885LMNA 2708/4885HIF1A 2582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback